Alexis Borisy - May 9, 2022 Form 4/A - Amendment Insider Report for OPKO HEALTH, INC. (OPK)

Role
Director
Signature
Steven D. Rubin, Attorney-in-Fact
Stock symbol
OPK
Transactions as of
May 9, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/13/2022, 06:19 PM
Date Of Original Report
May 11, 2022
Previous filing
Dec 20, 2021
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPK Common Stock Award $0 +313K $0.00 313K May 9, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPK Stock Option (Right to Buy) Award $0 +50K $0.00 50K May 9, 2022 Common Stock 50K $2.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 9, 2022, the Issuer awarded the Reporting Person restricted stock in the amount indicated in connection with the merger between the Issuer and ModeX Therapeutics, Inc. ("ModeX"), pursuant to which ModeX became a subsidiary of the Issuer.

Remarks:

This form is being amended to correct the footnote to Column 4 in Table I.